Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zofia Kozak

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Psychiatry|May 30, 2024
The Long Road Toward Equitable MDMA Treatment in the United StatesZofia Kozak, Scott T Aaronson
Med (New York, N.Y.)|February 15, 2024
New evidence for flexible psilocybin dosing in patients with treatment-resistant depressionScott T Aaronson, Zofia Kozak
Journal of the Academy of Consultation-Liaison Psychiatry|December 15, 2022
Patients With Schizophrenia-Spectrum Disorders as Vulnerable Populations in an Age of Misinformation: A Case Report of Ivermectin-Related Liver FailureNicholas Fioravante, Zofia Kozak, David Glovinsky
Harvard Review of Psychiatry|March 17, 2025
Therapeutic and Structural Dimensions in Psychiatric Prescribing: Bridging Psychedelics and AntidepressantsChristopher W T Miller, Zofia Kozak
International Review of Psychiatry (Abingdon, England)|February 21, 2025
Beyond psychedelics: set and setting in general psychiatric practiceZofia Kozak, Christopher W T Miller
Psychodynamic Psychiatry|June 16, 2026
Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian LensChristopher W T Miller, Zofia Kozak
Expert Opinion on Investigational Drugs|October 23, 2023
Assessing potential of psilocybin for depressive disordersZofia Kozak, Matthew W Johnson, Scott T Aaronson
Cancer|December 18, 2023
Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancerJohannes Thrul, Zofia Kozak, Michael A Carducci, et al.
The American Journal on Addictions|September 17, 2023
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugsZofia Kozak, Glenna J Urquhart, Saba Rouhani, et al.
Harm Reduction Journal|February 15, 2023
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatmentZofia Kozak, Daniel Ciccarone, Johannes Thrul, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Psychiatry|May 30, 2024
The Long Road Toward Equitable MDMA Treatment in the United StatesZofia Kozak, Scott T Aaronson
Med (New York, N.Y.)|February 15, 2024
New evidence for flexible psilocybin dosing in patients with treatment-resistant depressionScott T Aaronson, Zofia Kozak
Journal of the Academy of Consultation-Liaison Psychiatry|December 15, 2022
Patients With Schizophrenia-Spectrum Disorders as Vulnerable Populations in an Age of Misinformation: A Case Report of Ivermectin-Related Liver FailureNicholas Fioravante, Zofia Kozak, David Glovinsky
Harvard Review of Psychiatry|March 17, 2025
Therapeutic and Structural Dimensions in Psychiatric Prescribing: Bridging Psychedelics and AntidepressantsChristopher W T Miller, Zofia Kozak
International Review of Psychiatry (Abingdon, England)|February 21, 2025
Beyond psychedelics: set and setting in general psychiatric practiceZofia Kozak, Christopher W T Miller
Psychodynamic Psychiatry|June 16, 2026
Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian LensChristopher W T Miller, Zofia Kozak
Expert Opinion on Investigational Drugs|October 23, 2023
Assessing potential of psilocybin for depressive disordersZofia Kozak, Matthew W Johnson, Scott T Aaronson
Cancer|December 18, 2023
Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancerJohannes Thrul, Zofia Kozak, Michael A Carducci, et al.
The American Journal on Addictions|September 17, 2023
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugsZofia Kozak, Glenna J Urquhart, Saba Rouhani, et al.
Harm Reduction Journal|February 15, 2023
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatmentZofia Kozak, Daniel Ciccarone, Johannes Thrul, et al.
Pageof 1